Skip to main content

Venture Philanthropy Strategies to Support Translational Research Workshop Summary (2009) / Chapter Skim
Currently Skimming:

Conclusion
Pages 53-56

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 53...
... Supported by donations from ordinary Americans, the foundation funded much of the research that led to the development of the polio vaccine, up to and including the final field tests that demonstrated the vaccine's viability in real-life settings. The foundation succeeded because it had the determination, insight, and energy to pursue an endeavor that neither public institutions nor private companies could pursue on their own.
Read the entire page →
From page 54...
... Fortunately, voluntary health organizations are helping to bridge the gap in the process of translating basic research into commercially viable product candidates, funding efforts to translate initial scientific discoveries into testable, clinical-stage drug development candidates, biomarkers, and diagnostic tools. This new model of venture philanthropy has been proven on the ground, not only in the pioneering work in polio, but in the current success of organizations like the National Cystic Fibrosis Foundation, whose venture philanthropy efforts have created a broad pipeline of drugs that are advancing rapidly toward the clinic.
Read the entire page →
From page 55...
... This workshop summary attempts to gather those experiences and insights into a single source so that they may be called upon by others who are looking to enter this field. Workshop chair Timothy Coetzee of Fast Forward of the National Multiple Sclerosis Society noted that embracing venture philanthropy does not mean turning away from original and basic science research.
Read the entire page →

Key Terms

  • voluntary health
  • health organizations
  • drug development
  • translational research
  • translating basic

  • product candidates
  • commercially viable
  • viable product
  • evermore critical
  • development sector

  • philanthropy model
  • increasingly focused
  • government funding
  • double bottom
  • real risks

  • broad pipeline
  • drug discovery
  • research process
  • timothy coetzee
  • developing translational

  • funding increasingly
  • unique position
  • development research
  • instead engage
  • initial assessment

  • engage directly
  • embracing venture
  • initial scientific
  • diagnostic tools
  • uniquely suited


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.